Literature DB >> 15629000

Growth hormone (GH): usage and abuse.

Almira Hadzović1, Emina Nakas-Ićindić, Elma Kucukalić-Selimović, Abdul-Umid Salaka.   

Abstract

Growth hormone is essential for body growth but it also modulates metabolic pathways as well as neural, reproductive, immune, cardiovascular, and pulmonary functions. Numerous beneficial effects of growth hormone have led to its expanded therapeutic use in both children and adults. There are several officially approved applications of human growth hormone and many more proposed applications that resulted from huge number of clinical studies on GH therapy. Growth hormone abuse includes improper or excessive use. Over the last decade GH has become one of the most commonly abused drugs in sport due to the fact that its administration is currently undetectable. Enormous doses that are injected and frequent simultaneous abuse of other substances such as other anabolic steroids (testosterone) lead to frequent side effects that may be fatal. In spite of numerous beneficial effects of growth hormone the true physiological impact of GH replacement therapy on various metabolic parameters may be confounded by the dose and route of administration of GH so accurate physicians' monitoring during GH therapy is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15629000      PMCID: PMC7245490          DOI: 10.17305/bjbms.2004.3365

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  28 in total

1.  Supraphysiological doses of GH induce rapid changes in cardiac morphology and function.

Authors:  Antonio Cittadini; Annika Berggren; Salvatore Longobardi; Christer Ehrnborg; Raffaele Napoli; Thord Rosén; Serafino Fazio; Kenneth Caidahl; Bengt-Ake Bengtsson; Luigi Saccà
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

2.  Human growth hormone available for AIDS wasting.

Authors:  D Gilden
Journal:  GMHC Treat Issues       Date:  1995-01

3.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

4.  Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters.

Authors:  M S Nieminen; M P Rämö; M Viitasalo; P Heikkilä; J Karjalainen; M Mäntysaari; J Heikkilä
Journal:  Eur Heart J       Date:  1996-10       Impact factor: 29.983

5.  Growth hormone directly stimulates gluconeogenesis in canine renal proximal tubule.

Authors:  S A Rogers; I E Karl; M R Hammerman
Journal:  Am J Physiol       Date:  1989-11

6.  Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer.

Authors:  John K Triantafillidis; Emmanuel Merikas; Vasillios Govosdis; Evangelia Konstandellou; Petros Cheracakis; Charalambos Barbatzas; Dimitrios Tzourmakliotis; George Peros
Journal:  Hepatogastroenterology       Date:  2003-12

7.  Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis.

Authors:  Dominique Darmaun; Valerie Hayes; David Schaeffer; Susan Welch; Nelly Mauras
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Epiphyseal stapling and recombinant human growth hormone for correction of genu valgum in children with chronic renal insufficiency.

Authors:  Abiodun A Omoloja; Kush Kumar; Alvin H Crawford; C Frederic Strife
Journal:  J Pediatr Orthop       Date:  2003 Sep-Oct       Impact factor: 2.324

9.  The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.

Authors:  A Binnerts; G R Swart; J H Wilson; N Hoogerbrugge; H A Pols; J C Birkenhager; S W Lamberts
Journal:  Clin Endocrinol (Oxf)       Date:  1992-07       Impact factor: 3.478

10.  The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.

Authors:  Targ Elgzyri; Jan Castenfors; Erik Hägg; Christer Backman; Marja Thorén; Margareta Bramnert
Journal:  Clin Endocrinol (Oxf)       Date:  2004-07       Impact factor: 3.478

View more
  2 in total

1.  Strong diabetes.

Authors:  James Young; Aresh Anwar
Journal:  Br J Sports Med       Date:  2007-02-26       Impact factor: 13.800

2.  Strong diabetes.

Authors:  James Young; Aresh Anwar
Journal:  BMJ Case Rep       Date:  2009-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.